ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2019. The put-call ratio across all filers is 3.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $42,000 | -39.1% | 16,969 | -74.2% | 0.00% | -20.0% |
| Q3 2018 | $69,000 | – | 65,769 | +24349.4% | 0.01% | – |
| Q2 2018 | $0 | -100.0% | 269 | -89.9% | 0.00% | – |
| Q1 2018 | $4,000 | -71.4% | 2,669 | -41.6% | 0.00% | -100.0% |
| Q4 2017 | $14,000 | +100.0% | 4,569 | -33.5% | 0.00% | – |
| Q3 2017 | $7,000 | -72.0% | 6,869 | -75.4% | 0.00% | -100.0% |
| Q2 2017 | $25,000 | +257.1% | 27,900 | +527.1% | 0.00% | – |
| Q1 2017 | $7,000 | +250.0% | 4,449 | -47.3% | 0.00% | – |
| Q4 2016 | $2,000 | -60.0% | 8,449 | -37.2% | 0.00% | – |
| Q3 2016 | $5,000 | -82.8% | 13,449 | -6.6% | 0.00% | -100.0% |
| Q2 2016 | $29,000 | +123.1% | 14,400 | +364.5% | 0.00% | 0.0% |
| Q1 2016 | $13,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |